Online citations, reference lists, and bibliographies.
Referencing for people who value simplicity, privacy, and speed.
Get Citationsy
← Back to Search

Development Of Biodegradable Microspheres And Nanospheres For The Controlled Release Of Cyclosporin A

A. Sánchez, J. L. Vila-jato, M. Alonso
Published 1993 · Chemistry

Save to my Library
Download PDF
Analyze on Scholarcy Visualize in Litmaps
Share
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Get Citationsy
Abstract With the aim to develop a new controlled release dosage form of administration for cyclosporin A (CyA), several formulations of CyA-loaded microspheres and nanospheres based on poly( dl -lactide-co-glycolide) (PLGA) were designed. Microspheres and nanospheres, prepared by the solvent evaporation process, were characterized with respect to morphology, size distribution, drug content, internal structure and in vitro drug release. The micro- and nanospheres designed displayed various sizes (from 0.2 to 30 μm), spherical shape and smooth surface. The loading capacity was high for all formulations although it was influenced by the microsphere size. Results obtained by reversed-phase high-performance liquid chromatography, gel-permeation chromatography, differential scanning calorimetry, X-ray powder diffraction and Fourier transform infrared spectroscopy revealed that the peptide forms a molecular dispersion in the co-polymer matrix and no chemical interaction between co-polymer and drug occurs. Release profiles of CyA from the microspheres developed displayed a biphasic shape. The duration and intensity of each phase were affected by the microsphere size and the molecular weight of PLGA. Consequently, using PLGA it is possible to design micro- and nanospheres which allow the controlled release of CyA over a prolonged period of time. This may represent an interesting approach to provide therapeutic levels of the drug for extended periods of time.
This paper references
10.1097/00007890-198706000-00004
Effects of cyclosporine on the isolated perfused rat kidney.
D. Luke (1987)
10.1002/JPS.2600790307
Pharmacokinetics of two alternative dosage forms for cyclosporine: liposomes and intralipid.
S. Venkataram (1990)
10.1111/j.2042-7158.1989.tb06377.x
The Uptake and Translocation of Latex Nanospheres and Microspheres after Oral Administration to Rats
P. Jani (1989)
10.3109/02652048909098016
Selective transfer of cyclosporin to thoracic lymphatic systems by the application of lipid microspheres.
A. Yanagawa (1989)
10.1016/0168-3659(91)90071-K
Preparation of poly(l-lactide) microspheres of different crystalline morphology and effect of crystalline morphology on drug release rate
S. Izumikawa (1991)
10.3109/03639049209069315
Preparation of Poly(D,L-Lactide/Glycolide) Nanoparticles of Controlled Particle Size Distribution: Application of Experimental Designs
M. Julienne (1992)
HPLC of proteins and peptides in the pharmaceutical industry
K. Benedek (1991)
10.1111/j.2042-7158.1990.tb07033.x
Nanoparticle Uptake by the Rat Gastrointestinal Mucosa: Quantitation and Particle Size Dependency
P. Jani (1990)
10.3109/03639048809151937
Controlled Release of Cyclosporine from Microspheres
M. D'souza (1988)
10.1177/088532828700200103
Tissue Response to Biodegradable Injectable Microcapsules
G. Visscher (1987)
10.1111/j.1749-6632.1986.tb20879.x
Cyclosporine as a New Approach to Therapy of Autoimmune Diseases
J. Borel (1986)
Les technologies d'embolisation sélective, l'utilisation des microsphères
J. Benoit (1986)
Pharmacologic aspects of cyclosporine therapy: pharmacokinetics.
A. Wood (1985)
10.1111/j.2042-7158.1986.tb04561.x
The formation and characterization of hydrocortisone‐loaded poly((±)‐lactide) microspheres
M. Cavalier (1986)
10.1016/0168-3659(90)90133-E
Controlled vaccine release in the gut-associated lymphoid tissues. I. Orally administered biodegradable microspheres target the peyer's patches
J. Eldridge (1990)
10.1002/JPS.2600730927
Controlled release of a luteinizing hormone-releasing hormone analogue from poly(d,l-lactide-co-glycolide) microspheres.
L. M. Sanders (1984)
10.1159/000318463
Formulation of Dosage Forms
T. Cavanak (1986)
10.1016/0168-3659(87)90074-5
Prolonged delivery of peptides by microcapsules
H. V. Maulding (1987)
10.3109/03639049209046331
Formulation concerns of protein drugs
T. Chen (1992)



This paper is referenced by
Desarrollo de nuevos vehículos para la administración de vacunas genéticas
N. Csaba (2005)
10.1080/026520400417658
Biodegradable nanoparticles as a delivery system for cyclosporine: preparation and characterization.
J. Molpeceres (2000)
10.1163/156856297X00083
Synthesis, characterization, biodegradation, and drug delivery application of biodegradable lactic/glycolic acid oligomers: I. Synthesis and characterization.
N. Wang (1997)
10.1007/0-306-46803-4_10
Oral delivery of microencapsulated proteins.
M. D. DiBiase (1997)
10.1016/J.NANO.2005.12.003
Nanoencapsulation I. Methods for preparation of drug-loaded polymeric nanoparticles.
C. Reis (2006)
10.1076/ceyr.24.1.39.5427
Efficacy and safety of microspheres of cyclosporin A, a new systemic formulation, to prevent corneal graft rejection in rats
Ana I Vallelado (2002)
10.1016/J.IJPHARM.2007.03.035
Drug release study of large hollow nanoparticulate aggregates carrier particles for pulmonary delivery.
Kunn Hadinoto (2007)
10.1016/j.peptides.2015.05.012
Antimicrobial peptides: Possible anti-infective agents
Jayaram Lakshmaiah Narayana (2015)
10.1016/S0168-3659(02)00212-2
Paclitaxel-loaded PLGA nanoparticles: preparation, physicochemical characterization and in vitro anti-tumoral activity.
Cristina Fonseca (2002)
10.3109/10611869808997871
Drug delivery systems for cyclosporine: achievements and complications.
B. A. Klyashchitsky (1998)
10.7314/APJCP.2014.15.23.10281
Synthesis, characterization and in vitro anti-tumoral evaluation of Erlotinib-PCEC nanoparticles.
Leila Barghi (2014)
10.1023/A:1018936815654
Preparation of Three-Month Depot Injectable Microspheres of Leuprorelin Acetate Using Biodegradable Polymers
Hiroaki Okada (2004)
10.1146/ANNUREV.MATSCI.36.032905.091005
THE USE OF POLYMER DESIGN IN RESORBABLE COLLOIDS
A. Finne-Wistrand (2006)
10.1016/j.colsurfb.2008.09.001
The enhancement of immunosuppressive effects of cyclosporine A on human T-cells using fusogenic liposomes.
B. Malaekeh-Nikouei (2008)
10.1208/s12248-009-9081-8
Poly(ethylene glycol)-Modified Proteins: Implications for Poly(lactide-co-glycolide)-Based Microsphere Delivery
S. S. Pai (2009)
10.1023/A:1018901619230
Development and Characterization of Microencapsulated Microspheres
A. Göpferich (2004)
10.1016/S0168-3659(03)00152-4
Carbon dioxide extraction of residual solvents in poly(lactide-co-glycolide) microparticles.
J. Herberger (2003)
10.1016/S1773-2247(06)50063-2
The effect of complexation on characteristics and drug release from PLGA microspheres loaded by cyclosporine-cyclodextrin complex
B. Malaekeh-Nikouei (2006)
10.1111/jphp.12118
Improved percutaneous delivery of ketoprofen using combined application of nanocarriers and silicon microneedles
S. Vucen (2013)
10.1590/1678-9199-JVATITD-1441-18
Nanoparticulate drug delivery systems for the treatment of neglected tropical protozoan diseases
Greta Volpedo (2019)
10.1016/S0378-5173(98)00298-1
Comparative study of 'in vitro' release of anti-inflammatory drugs from polylactide-co-glycolide microspheres
F. Castelli (1998)
10.1016/S0169-409X(97)00050-1
One- and three-month release injectable microspheres of the LH-RH superagonist leuprorelin acetate.
Okada (1997)
10.1016/j.exer.2014.06.013
28-day intraocular pressure reduction with a single dose of brimonidine tartrate-loaded microspheres.
M. Fedorchak (2014)
10.1007/S003960050130
A mechanistic study of the formation of polymer nanoparticles by the emulsification-diffusion technique
D. Quintanar-Guerrero (1997)
Microesferas de PLGA: un sistema para la liberación controlada de moléculas con actividad inmunogénica
J. Rosas (2007)
10.1016/S0168-3659(98)00146-1
Modification of release rates of cyclosporin A from polyl(L-lactic acid) microspheres by fatty acid esters and in-vivo evaluation of the microspheres.
T. Urata (1999)
10.1016/S0031-6865(97)00013-7
In vitro characterization of methotrexate loaded poly(lactic-co-glycolic) acid microspheres and antitumor efficacy in Sarcoma-180 mice bearing tumor.
U. V. Singh (1997)
10.3109/03639049809108571
Preparation techniques and mechanisms of formation of biodegradable nanoparticles from preformed polymers.
D. Quintanar-Guerrero (1998)
10.1007/12_2012_198
Biodegradable Polymers for Potential Delivery Systems for Therapeutics
S. K. Pandey (2013)
10.1208/s12249-011-9661-7
Microparticulate Based Topical Delivery System of Clobetasol Propionate
Ulya Badilli (2011)
10.1080/026520400417658
Biodegradable nanoparticles as a delivery system for cyclosporine: preparation and characterization
J. Molpeceres, M. R. Aberturas, M. Guzman (2000)
10.1002/JPS.20446
Rheological and dielectric characterization of monoolein/water mesophases in the presence of a peptide drug.
G. Bonacucina (2005)
See more
Semantic Scholar Logo Some data provided by SemanticScholar